Vol 27, No 4 (2020)
Study Protocol
Published online: 2020-06-29
Ion channel inhibition against COVID-19: A novel target for clinical investigation
1, 2, 3, 4
, 1
, 1
Abstract
Not available
References
- Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020; 39(5): 405–407.
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181(2): 271–280.e8.
- Inoue Y, Tanaka N, Tanaka Y, et al. Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol. 2007; 81(16): 8722–8729.
- Lai AL, Millet JK, Daniel S, et al. The SARS-CoV fusion peptide forms an extended bipartite fusion platform that perturbs membrane order in a calcium-dependent manner. J Mol Biol. 2017; 429(24): 3875–3892.
- Straus MR, Tang T, Lai AL, et al. Ca ions promote fusion of middle east respiratory syndrome coronavirus with host cells and increase infectivity. J Virol. 2020; 94(13).
- Qian Z, Dominguez SR, Holmes KV. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One. 2013; 8(10): e76469.
- Tang T, Bidon M, Jaimes JA, et al. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antiviral Res. 2020; 178: 104792.
- Basso LGM, Vicente EF, Crusca E, et al. SARS-CoV fusion peptides induce membrane surface ordering and curvature. Sci Rep. 2016; 6: 37131.
- de Haan CAM, Rottier PJM. Molecular interactions in the assembly of coronaviruses. Adv Virus Res. 2005; 64: 165–230.
- Raffaello A, Mammucari C, Gherardi G, et al. Calcium at the center of cell signaling: interplay between endoplasmic reticulum, mitochondria, and lysosomes. Trends Biochem Sci. 2016; 41(12): 1035–1049.
- Huotari J, Helenius A. Endosome maturation. EMBO J. 2011; 30(17): 3481–3500.
- Pryor PR, Mullock BM, Bright NA, et al. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J Cell Biol. 2000; 149(5): 1053–1062.
- Stadler K, Ha HR, Ciminale V, et al. Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. Am J Respir Cell Mol Biol. 2008; 39(2): 142–149.
- Gehring G, Rohrmann K, Atenchong N, et al. The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother. 2014; 69(8): 2123–2131.
- Salata C, Baritussio A, Munegato D, et al. Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process. Pathog Dis. 2015; 73(5).
